Detection of clinically significant index prostate cancer using micro-ultrasound: correlation with radical prostatectomy.
By: Matias F Callejas, Eric A Klein, Matt Truong, Lewis Thomas, Jesse K McKenney, Sangeet Ghai

Toronto Joint Department of Medical Imaging, University Health Network - Mt Sinai Hospital - Women's College Hospital, University of Toronto. Toronto, Ontario, Canada.
2022-02-16; doi: 10.1016/j.urology.2022.07.002
Abstract

Objective

To determine the detection of clinically significant prostate cancer (csPCa) index lesion using high resolution transrectal micro-ultrasound (MicroUS) applying PRI-MUS (Prostate Risk Identification using Micro Ultrasound) score v1.0.

Methods

Men who underwent radical prostatectomy following biopsy and MicroUS assessment were included. MicroUS dynamic cine loops of these patients were retrospectively reviewed by an experienced radiologist. The radiologist was aware that patients had undergone radical prostatectomy but was blinded to pathological data. Suspicious sites were assigned a PRI-MUS score. Radical prostatectomy specimens were examined with quarter mount technique. Detection rate of csPCa index lesion [Grade Group (GG) ≥2] by MicroUS was assessed at a patient level.

Results

Twenty-five participants were included in the analysis. The median age was 65.5 years (range 56 - 74). Median PSA was 6.45 ng/dL (range 2 - 31.72). Two of 25 patients did not have csPCa (GG1 disease) on radical prostatectomy. MicroUS visualized 20/23 (87%) of the csPCa index lesions [median length 9 mm (range 1.5- 28.5)]. All identified lesions were categorized PRIMUS score 4 or 5. The 3 missed index lesions were in the transition zone [median length 10.5 mm (range 4.5-22.5)]. MicroUS missed 11 non index csPCa in 9 participants [median length 1.5 mm (range 1.5-10.5)]. Of these, 8 were GG2, two GG3 and one GG5. MicroUS identified the csPCa index lesion in all 9 of these men.

Conclusion

MicroUS showed high sensitivity (87%) in detecting index lesions in the prostate gland and identified 100% of index lesions in the peripheral zone.



Copyright © 2022. Published by Elsevier Inc.

PMID:35843353






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements